USP1 Regulates TAZ Protein Stability Through Ubiquitin Modifications in Breast Cancer

Ashley Mussell1, He Shen1, Yanmin Chen1

  • 1Department of Cancer Genetics & Genomics, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14203, USA.

Cancers
|October 29, 2020
PubMed

Insights

Ubiquitin specific peptidase 1 (USP1) regulates TAZ protein stability, impacting breast cancer cell proliferation and migration. USP1 and TAZ show a positive correlation in patients, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The Hippo signaling pathway, conserved from Drosophila to mammals, regulates cell growth and organ size.
  • Key effectors YAP/TAZ are frequently dysregulated in cancers, promoting proliferation, migration, and metastasis.
  • Understanding YAP/TAZ protein regulation is crucial for targeting cancer phenotypes.

Purpose of the Study:

  • To identify novel regulators of TAZ (WWTR1) protein at the post-translational level.
  • To investigate the role of deubiquitinating enzymes (DUBs) in TAZ regulation.
  • To explore the therapeutic potential of targeting TAZ regulation in breast cancer.

Main Methods:

  • Conducted an siRNA library screen targeting deubiquitinating enzymes (DUBs).
  • Utilized co-immunoprecipitation to assess protein-protein interactions.
  • Quantified protein levels, ubiquitination status, and cell proliferation/migration assays.
  • Analyzed patient data for correlation between USP1 and TAZ expression.

Main Results:

  • Identified ubiquitin specific peptidase 1 (USP1) as a novel regulator of TAZ.
  • Demonstrated that USP1 interacts with TAZ and enhances its protein stability.
  • USP1 depletion leads to increased TAZ poly-ubiquitination, reduced TAZ levels, and decreased breast cancer cell proliferation and migration.
  • Observed a significant positive correlation between USP1 and TAZ expression in breast cancer patient samples.

Conclusions:

  • USP1 deubiquitinase activity stabilizes TAZ protein, promoting malignant phenotypes in breast cancer.
  • USP1-TAZ interaction represents a potential therapeutic target for breast cancer.
  • Findings elucidate the crosstalk between USP1 and the Hippo pathway, offering insights for novel treatment strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.3K